NEPH
NEPHROS INC
Key Financials
Revenue
$18.8M
↑ 32.7%
Net Income
$1.2M
↑ 1513.5%
Gross Profit
$11.6M
↑ 33.3%
Operating Income
$1.1M
↑ 19000.0%
EPS (Diluted)
$0.11
↑ 1000.0%
Total Liabilities
$3.4M
↑ 31.0%
Total Assets
$13.6M
↑ 21.7%
Cash & Equivalents
$5.4M
↑ 43.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D/A | 9/16/2026 | View on SEC |
| SCHEDULE 13G | 9/16/2026 | View on SEC |
| 4 | 9/16/2026 | View on SEC |
| 4 | 9/16/2026 | View on SEC |
| 4 | 8/20/2026 | View on SEC |
| 4 | 8/14/2026 | View on SEC |
| 10-Q | 8/10/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| 8-K | 6/15/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NEPH |
| Company Name | NEPHROS INC |
| CIK | 1196298 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 201.343.5202 |